Shirish Sangle

2.6k total citations
53 papers, 1.6k citations indexed

About

Shirish Sangle is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Shirish Sangle has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Rheumatology, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Shirish Sangle's work include Systemic Lupus Erythematosus Research (35 papers), Vasculitis and related conditions (18 papers) and Renal Diseases and Glomerulopathies (8 papers). Shirish Sangle is often cited by papers focused on Systemic Lupus Erythematosus Research (35 papers), Vasculitis and related conditions (18 papers) and Renal Diseases and Glomerulopathies (8 papers). Shirish Sangle collaborates with scholars based in United Kingdom, Spain and Canada. Shirish Sangle's co-authors include David D’Cruz, Geneviève Depresseux, Frédéric Houssiau, Christoph Fiehn, Isabelle Ravelingien, Maria G. Tektonidou, Philippe Rémy, Loı̈c Guillevin, Véronique Le Guern and Ricard Cervera and has published in prestigious journals such as The Journal of Immunology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Shirish Sangle

48 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shirish Sangle United Kingdom 23 1.1k 439 416 332 281 53 1.6k
Micol Frassi Italy 17 1.0k 0.9× 108 0.2× 517 1.2× 215 0.6× 476 1.7× 31 1.6k
Mary‐Carmen Amigo Mexico 23 1.3k 1.2× 327 0.7× 308 0.7× 123 0.4× 212 0.8× 50 1.6k
Chi Hung To China 24 1.5k 1.4× 330 0.8× 747 1.8× 236 0.7× 106 0.4× 45 2.0k
Guillermo Pons‐Estel United States 24 2.3k 2.1× 422 1.0× 1.1k 2.7× 407 1.2× 142 0.5× 66 2.7k
Javier Cabiedes Mexico 25 1.8k 1.6× 202 0.5× 527 1.3× 552 1.7× 116 0.4× 60 2.3k
Murat İnanç Türkiye 28 1.6k 1.4× 219 0.5× 746 1.8× 217 0.7× 635 2.3× 134 2.9k
Paz Lavilla Spain 7 1.9k 1.7× 311 0.7× 1.0k 2.4× 433 1.3× 104 0.4× 8 2.1k
J. D. Reveille United States 20 2.1k 1.8× 202 0.5× 1.3k 3.1× 291 0.9× 104 0.4× 32 2.6k
Micaela Fredi Italy 25 1.1k 1.0× 124 0.3× 610 1.5× 181 0.5× 110 0.4× 89 1.7k
Ricardo Forastiero Argentina 26 1.7k 1.5× 242 0.6× 336 0.8× 393 1.2× 136 0.5× 59 2.1k

Countries citing papers authored by Shirish Sangle

Since Specialization
Citations

This map shows the geographic impact of Shirish Sangle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirish Sangle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirish Sangle more than expected).

Fields of papers citing papers by Shirish Sangle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shirish Sangle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirish Sangle. The network helps show where Shirish Sangle may publish in the future.

Co-authorship network of co-authors of Shirish Sangle

This figure shows the co-authorship network connecting the top 25 collaborators of Shirish Sangle. A scholar is included among the top collaborators of Shirish Sangle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirish Sangle. Shirish Sangle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nel, Louise, et al.. (2024). P49 Belimumab as a potential therapy for lupus enteritis – a case report. Rheumatology Advances in Practice. 8(Supplement_1). 1 indexed citations
2.
Sangle, Shirish, et al.. (2024). Lupus enteritis: a narrative review. Lara D. Veeken. 63(6). 1494–1501. 8 indexed citations
3.
4.
Kim, Sangmi, Lena Boehme, Louise Nel, et al.. (2022). Defective STAT5 Activation and Aberrant Expression of BCL6 in Naive CD4 T Cells Enhances Follicular Th Cell–like Differentiation in Patients with Granulomatosis with Polyangiitis. The Journal of Immunology. 208(4). 807–818. 8 indexed citations
5.
Casian, Alina, Shirish Sangle, & David D’Cruz. (2018). New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis. Autoimmunity Reviews. 17(7). 660–664. 27 indexed citations
6.
Drott, Ulrich, Harald Burkhardt, Shirish Sangle, et al.. (2018). High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 77(11). 1590–1598. 44 indexed citations
7.
Subesinghe, Sujith, et al.. (2017). Cocaine and ANCA associated vasculitis-like syndromes – A case series. Autoimmunity Reviews. 17(1). 73–77. 25 indexed citations
8.
Sangle, Shirish, Annette Briley, Louise Nel, et al.. (2015). Pregnancy outcome in patients with systemic vasculitis: a single-centre matched case-control study. Lara D. Veeken. 54(9). 1582–1586. 24 indexed citations
9.
Tamirou, Farah, David D’Cruz, Shirish Sangle, et al.. (2015). Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis. Annals of the Rheumatic Diseases. 75(3). 526–531. 136 indexed citations
10.
Sangle, Shirish, et al.. (2014). B cell depletion therapy and eosinophilic granulomatosis with polyangiitis with hepatic involvement. Lara D. Veeken. 53(10). 1741–1741. 3 indexed citations
11.
Sangle, Shirish, Pamela Lutalo, Rachel Davies, Munther A. Khamashta, & David D’Cruz. (2013). B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases. Journal of Autoimmunity. 43. 55–59. 35 indexed citations
12.
Díaz‐Lagares, Cándido, Sara Croca, Shirish Sangle, et al.. (2011). Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts. Autoimmunity Reviews. 11(5). 357–364. 173 indexed citations
13.
Jordan, Natasha, et al.. (2011). Dacryoadenitis and Diffuse Orbital Inflammation: Unusual First Presentations of Churg-Strauss Syndrome. Orbit. 30(3). 160–161. 5 indexed citations
14.
Houssiau, Frédéric, David D’Cruz, Shirish Sangle, et al.. (2010). Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial. Annals of the Rheumatic Diseases. 69(12). 2083–2089. 331 indexed citations
15.
Sangle, Shirish, et al.. (2009). Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis. PubMed. 6(1). 3–3. 9 indexed citations
16.
Sangle, Shirish, R. Jeremy H. Davies, Marta Mora-Rillo, et al.. (2008). Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis. Lara D. Veeken. 47(7). 1058–1060. 13 indexed citations
17.
Rosenthal, Éric, Shirish Sangle, Munther A. Khamashta, David D’Cruz, & Graham R.V. Hughes. (2006). Manifestations osseuses du syndrome des antiphospholipides. La Revue de Médecine Interne. 28(2). 103–107. 4 indexed citations
18.
Sangle, Shirish. (2004). Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. British journal of rheumatology. 44(3). 372–377. 31 indexed citations
19.
Sangle, Shirish, et al.. (2004). Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures. Annals of the Rheumatic Diseases. 63(10). 1241–1243. 31 indexed citations
20.
Sangle, Shirish, et al.. (2003). Prevalence of hypertension in 600 patients with antiphospholipid syndrome.. Research Portal (King's College London). 48(9). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Micol Frassi Breakdown of academic impact, for papers by Mary‐Carmen Amigo Breakdown of academic impact, for papers by Chi Hung To Breakdown of academic impact, for papers by Guillermo Pons‐Estel Breakdown of academic impact, for papers by Javier Cabiedes Breakdown of academic impact, for papers by Murat İnanç Breakdown of academic impact, for papers by Paz Lavilla Breakdown of academic impact, for papers by J. D. Reveille Breakdown of academic impact, for papers by Micaela Fredi Breakdown of academic impact, for papers by Ricardo Forastiero
Rankless by CCL
2026